{"id":293317,"date":"2026-10-08T09:48:52","date_gmt":"2026-10-08T04:18:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=293317"},"modified":"2026-10-16T09:37:36","modified_gmt":"2026-10-16T04:07:36","slug":"why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/","title":{"rendered":"Laurus Labs (LAURUSLABS) 52 Week High Streak: Eighth Straight Session Near One-Year Peak"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\">Laurus Labs Ltd. (LAURUSLABS)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 2,032, up 0.59% from the previous close. Market cap was Rs 1,10,007.57 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Laurus Labs 52 Week High Streak has now lasted for its eighth consecutive session, with the stock trading near its one-year peak rather than setting a fresh benchmark today. Over this stretch, the cumulative move is -1.07%, while the latest session saw the share price move between Rs 2,027.35 and Rs 2,044.6 and last trade at Rs 2,032. According to latest Univest data, the pattern is confirmed, but it does not establish a company-specific catalyst for the continued move.<\/p>\n<p style=\"margin-top:0!important;\">At Rs 2020, the previous session level offers the near-term reference point, while today\u2019s open matched the day\u2019s low at Rs 2,027.35. Laurus Labs Ltd. carries a market capitalisation of Rs 1,10,007.57 crore, placing the latest price action in a large-company setting that readers often track alongside fundamentals, valuation and sector comparison. For readers, the repeated near-high pattern is more informative than a single strong print because it shows persistence across sessions, not just one intraday move.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Laurus_Labs_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Laurus Labs 52 Week High Streak: Consecutive High Analysis\">Laurus Labs 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Laurus_Labs_Ltd_LAURUSLABS_Fundamental_Analysis\" title=\"Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis\">Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_Laurus_Labs\" title=\"Why Investors Are Watching Laurus Labs\">Why Investors Are Watching Laurus Labs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#About_Laurus_Labs_Ltd\" title=\"About Laurus Labs Ltd.\">About Laurus Labs Ltd.<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_does_the_Laurus_Labs_52_Week_High_Streak_mean\" title=\"What does the Laurus Labs 52 Week High Streak mean?\">What does the Laurus Labs 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#How_many_consecutive_sessions_has_Laurus_Labs_stayed_near_its_yearly_high\" title=\"How many consecutive sessions has Laurus Labs stayed near its yearly high?\">How many consecutive sessions has Laurus Labs stayed near its yearly high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_is_the_cumulative_move_across_the_streak\" title=\"What is the cumulative move across the streak?\">What is the cumulative move across the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Is_a_company-specific_catalyst_confirmed_for_the_repeated_near-high_trading\" title=\"Is a company-specific catalyst confirmed for the repeated near-high trading?\">Is a company-specific catalyst confirmed for the repeated near-high trading?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#How_does_Laurus_Labs_compare_with_peers_on_valuation\" title=\"How does Laurus Labs compare with peers on valuation?\">How does Laurus Labs compare with peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_do_ROE_and_ROCE_show_for_Laurus_Labs\" title=\"What do ROE and ROCE show for Laurus Labs?\">What do ROE and ROCE show for Laurus Labs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Why_is_market_capitalisation_relevant_here\" title=\"Why is market capitalisation relevant here?\">Why is market capitalisation relevant here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#What_should_investors_watch_next_in_Laurus_Labs_share_price_updates\" title=\"What should investors watch next in Laurus Labs share price updates?\">What should investors watch next in Laurus Labs share price updates?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-laurus-labs-ltd-share-near-52-week-consecutive-high-2026\/#Track_Laurus_Labs_Ltd_LAURUSLABS_Share_Price_on_Univest\" title=\"Track Laurus Labs Ltd. (LAURUSLABS) Share Price on Univest\">Track Laurus Labs Ltd. (LAURUSLABS) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Laurus_Labs_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Laurus Labs 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,032<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,020<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 12 (+0.59%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,027.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,044.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,027.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,10,007.57 crore<\/td>\n<\/tr>\n<\/table>\n<p>Laurus Labs Ltd. (LAURUSLABS) traded at Rs 2,032 versus the previous close of Rs 2,020, a rise of 0.59%. The stock opened at Rs 2,027.35, reached a high of Rs 2,044.6 and touched a low of Rs 2,027.35.<\/p>\n<p>Laurus Labs Share Price Today is trading at Rs 2032, up Rs 12 or 0.59% from the previous level of Rs 2,020. The stock opened at Rs 2,027.35, touched a high of Rs 2,044.6 and a low of Rs 2,027.35, which means the current price is positioned in the upper half of the day\u2019s range. That matters for traders reading the session alongside the broader Laurus Labs Stock News flow.<\/p>\n<p>The move keeps Laurus Labs Share Price close to its recent upper band without turning the session into a fresh breakout narrative. With a market cap of Rs 1,10,007.57 crore, Laurus Labs remains a sizeable Healthcare company and the share price action is being watched as part of a broader Laurus Labs Share Price Update rather than as a one-off swing. The current reading also keeps the stock in the conversation among 52 Week High Stocks, even though the latest print itself is best described as a near-high trade.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Laurus Labs 52 Week High Streak suggests persistence rather than a single-day price burst. The key point is the repetition: the stock has stayed within 2% of its 52-week high for eight straight sessions, which keeps it among Stocks At One Year High Today even when the exact intraday level changes. The latest Univest figures confirm the pattern, but they do not identify a fresh corporate trigger behind it.<\/p>\n<p>That matters because repeated near-high trading often changes how market readers frame the story. Instead of asking whether one strong session was a fluke, the better question becomes why the stock keeps remaining close to its yearly high. In Laurus Labs\u2019 case, the cumulative move across the streak is slightly negative at -1.07%, so the pattern is not a straight-line rise. It is a sustained near-peak range, which makes the Laurus Labs 52 Week High Streak a useful stock price signal to monitor alongside company updates and sector moves.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Laurus_Labs_Ltd_LAURUSLABS_Fundamental_Analysis\"><\/span><strong>Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,10,007.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">99.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20.24<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 104.37<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.1%<\/td>\n<\/tr>\n<\/table>\n<p>Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P\/E 99.82x, P\/B 19.35x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Laurus Labs Ltd. has a market capitalisation of Rs 1,10,007.57 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 99.82x, P\/B at 19.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 27.24x, median ROE of 11.32%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">99.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.24x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 640x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.32%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,10,007.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 795.25 crore<\/td>\n<\/tr>\n<\/table>\n<p>Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Laurus Labs Ltd. (LAURUSLABS) has a P\/E ratio of 99.82x, which is above the benchmark median of 27.24x, a difference of +266.45%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.32%, a difference of +61.75%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.17%, a difference of +38.19%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,119.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,06,061.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/drreddy\/dr-reddy&#39;s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Dr. Reddy&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRREDDY<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,01,338.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Mankind Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MANKIND<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">96,243.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">47.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.24<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/auropharma\/aurobindo-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aurobindo Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AUROPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">95,590.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.76<\/td>\n<\/tr>\n<\/table>\n<p>Laurus Labs Ltd. (LAURUSLABS) has a P\/E ratio of 99.82x compared with the displayed peer median of 31.62x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,10,007.57 crore. Among the 5 peers shown, 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Laurus_Labs\"><\/span><strong>Why Investors Are Watching Laurus Labs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock has traded within 2% of its 52-week high for the eighth consecutive session, which keeps the Laurus Labs 52 Week High Streak in focus.<\/li>\n<li>The cumulative streak move is -1.07%, so the pattern reflects repeated near-high trading rather than a one-direction run.<\/li>\n<li>Valuation remains elevated, with a P\/E of 99.82 and a P\/B of 19.35 versus lower industry medians.<\/li>\n<li>ROE of 18.31% and ROCE of 18.2% support the operating picture relative to many healthcare peers.<\/li>\n<li>Market capitalisation of Rs 1,10,007.57 crore keeps Laurus Labs in the large-company bracket for Stock Price tracking.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Laurus_Labs_Ltd\"><\/span><strong>About Laurus Labs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Laurus Labs Ltd. is part of the Healthcare sector and operates in the Pharmaceuticals &amp; Drugs industry. The company is followed closely by investors who track company financials, market capitalisation and sector positioning in relation to peer companies. Laurus Labs Stock News often attracts attention because the share price can stay in focus even when no new company-specific explanation is immediately confirmed.<\/p>\n<p>For readers following Laurus Labs Share Price Today, the combination of a high valuation, mid-to-strong return ratios and a large market cap creates a stock that is regularly compared with other major Indian pharmaceutical names. That is why the Laurus Labs 52 Week High Streak is being watched alongside fundamental numbers rather than in isolation.<\/p>\n<p><strong>Frequently Asked Questions<\/strong><\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_Laurus_Labs_52_Week_High_Streak_mean\"><\/span>What does the Laurus Labs 52 Week High Streak mean?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>It means Laurus Labs has traded within 2% of its 52-week high for eight straight sessions. The pattern shows repeated near-high trading, not necessarily a fresh one-day record, and the latest Univest figures do not confirm a specific company trigger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_consecutive_sessions_has_Laurus_Labs_stayed_near_its_yearly_high\"><\/span>How many consecutive sessions has Laurus Labs stayed near its yearly high?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Laurus Labs has stayed near its one-year high for eight consecutive sessions. That makes it an extended streak, and the current reading keeps the stock in the discussion of Stocks Hitting 52 Week Highs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_cumulative_move_across_the_streak\"><\/span>What is the cumulative move across the streak?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The cumulative move across the Laurus Labs 52 Week High Streak is -1.07%. This means the multi-session pattern has been close to the peak, but it has not produced a net gain over the entire streak.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_a_company-specific_catalyst_confirmed_for_the_repeated_near-high_trading\"><\/span>Is a company-specific catalyst confirmed for the repeated near-high trading?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>No company-specific catalyst is confirmed by the latest Univest data. The article can confirm the repeated price pattern, but it does not identify the reason behind the sustained near-high trading.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Laurus_Labs_compare_with_peers_on_valuation\"><\/span>How does Laurus Labs compare with peers on valuation?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Laurus Labs trades at a P\/E of 99.82 and a P\/B of 19.35, both above the medians in the same industry sample. That places it at a richer valuation than several listed healthcare peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_Laurus_Labs\"><\/span>What do ROE and ROCE show for Laurus Labs?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Laurus Labs has ROE of 18.31% and ROCE of 18.2%. Those are healthy return ratios and compare favourably with several peers, even though some companies in the group post stronger readings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_market_capitalisation_relevant_here\"><\/span>Why is market capitalisation relevant here?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Market capitalisation helps readers place the stock in context. Laurus Labs has a market cap of Rs 1,10,007.57 crore, which means its price action is being watched as part of a large-company healthcare story.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_watch_next_in_Laurus_Labs_share_price_updates\"><\/span>What should investors watch next in Laurus Labs share price updates?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Investors should track whether the stock continues to hold near its yearly high, whether valuation stays elevated relative to peers, and whether future company updates change the present price pattern. The Laurus Labs Share Price Update remains data-led.<\/p>\n<\/p>\n<p><\/content><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Laurus_Labs_Ltd_LAURUSLABS_Share_Price_on_Univest\"><\/span><strong>Track Laurus Labs Ltd. (LAURUSLABS) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\">Laurus Labs Ltd. (LAURUSLABS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Laurus Labs Ltd. Share Price trades near its 52-week high at Rs 2,032, marking a 0.59% rise today. Market cap stands at Rs 1,10,007.57 crore.<\/p>\n","protected":false},"author":38,"featured_media":312060,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-293317","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["312060"],"rank_math_title":["Laurus Labs 52 Week High Streak After Another Strong Session"],"rank_math_description":["Laurus Labs 52 Week High Streak continues for the eighth straight session, with the stock still trading near its one-year peak and valuation in focus."],"rank_math_focus_keyword":["Laurus Labs 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/laurus-labs-lauruslabs-52-week-high-streak-eighth-straight-session-near-one-year.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/293317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=293317"}],"version-history":[{"count":4,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/293317\/revisions"}],"predecessor-version":[{"id":312063,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/293317\/revisions\/312063"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/312060"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=293317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=293317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=293317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}